D3. Time from Collagenase Injection to Manipulation Does Not Affect Outcomes in Dupuytren’s Disease

D3. Time from Collagenase Injection to Manipulation Does Not Affect Outcomes in Dupuytren’s Disease

Bibliographic Details
Main Authors:	Elijah G. Bingham, BS, Purushottam Nagarkar, MD, Nirbhay S. Jain, MD, Meaghan L. Barr, MD, Cathy Tang, MD, Dong Lee, BS, Irene Chang, BS, Michael Delong, MD, Prosper Benhaim, MD
Format:	Article
Language:	English
Published:	Wolters Kluwer 2023-04-01
Series:	Plastic and Reconstructive Surgery, Global Open
Online Access:	http://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0000934624.83908.e2

Similar Items

Can You Go the Distance: Collagenase Clostridium histolyticum Manipulation at 1 Month after Injection
by: Lacey R. Pflibsen, MD, et al.
Published: (2023-09-01)

Acute Pain Intensity After Collagenase Clostridium histolyticum Injection in Patients With Dupuytren Contracture
by: Kimitoshi Noto, MD, et al.
Published: (2020-01-01)

Needle Fasciotomy or Collagenase Injection in the Treatment of Dupuytren’s Contracture: A Retrospective Study
by: Islam Abdelrahman, MRCS, FEBOPRAS, MD, PhD, et al.
Published: (2020-01-01)

Clostridium Histolyticum Collagenase Underdosed for Multicord Injection in Dupuytren’s Disease: A Retrospective Cohort Study
by: Filippo Boriani, MD, MSc, PhD, et al.
Published: (2022-11-01)

Comparative Effectiveness of Needle Aponeurotomy and Collagenase Injection for Dupuytren’s Contracture: A Multicenter Study
by: Chao Zhou, MD, et al.
Published: (2017-09-01)

Dupuytren Disease: A Retrospective Cohort Study Comparing Collagenase Injection and Percutaneous Needle Fasciotomy
by: Turkhan Mehdiyev, MD, et al.
Published: (2022-10-01)

Delayed vascular complication after collagenase injection for Dupuytren disease
by: Jesper Nordenskjöld, et al.
Published: (2023-10-01)

Real-world Medicare Healthcare Costs of Patients with Dupuytren’s Contracture Treated with Collagenase or Fasciectomy
by: Vladimir Zah, DPhil, et al.
Published: (2022-08-01)

111. A Long-term Comparison of Collagenase versus Fasciectomy in the Treatment of Dupuytren’s Contracture
by: Cyrus S. Steppe, BA, et al.
Published: (2023-05-01)

Comparison between Collagenase Injection and Partial Fasciectomy in the Treatment of Dupuytren’s Contracture
by: Tay, T.K.W., et al.
Published: (2015)

Collagenase injections for Dupuytren’s in Australian public hospitals: a cost analysis
by: Devlin Elliott, et al.
Published: (2019-03-01)

Use of Acellular Dermal Matrix Following Fasciectomy for the Treatment of Dupuytren’s Disease
by: Don Hoang, MD, et al.
Published: (2019-05-01)

Association between Stenosing Tenosynovitis and Dupuytren’s Contracture in the Hand
by: Kai Yang, MD, et al.
Published: (2019-01-01)

Multiple concurrent collagenase clostridium histolyticum injections to dupuytren’s cords: an exploratory study
by: Coleman Stephen, et al.
Published: (2012-04-01)

Tendinopathy Induced by Serial Low-Dose Collagenase Injections
by: Cesar Cesar Netto MD, et al.
Published: (2016-08-01)

Abstract: Correlation between Stenosing Tenosynovitis and Dupuytren’s Contracture in the Hand
by: Michael B. Gehring, BS, et al.
Published: (2018-09-01)

Unusual Intranodular Collagenase Injection: A Case of Bilateral Ledderhose Disease
by: Rocco De Vitis, MD, et al.
Published: (2020-04-01)

Different collagenase delivery for Dupuytren disease in public hospitals
by: Jessca A Paynter, et al.
Published: (2020-09-01)

Evaluation of a Teaching Module to Train Medical Students About the Pathogenesis and Presentation of Dupuytren’s Contracture
by: Michele Ryan, BS, et al.
Published: (2020-09-01)

Collagenase injections for Dupuytren disease: 3-year treatment outcomes and predictors of recurrence in 89 hands
by: Jesper Nordenskjöld, et al.
Published: (2019-11-01)

Magnetic resonance imaging of diffusion characteristics following collagenase clostridium histolyticum injection in Dupuytren’s contracture
by: Hiroko Iwakawa, et al.
Published: (2021-09-01)

P143. MANAGEMENT OF RADIAL NERVE PALSY: SYSTEMATIC REVIEW AND POOLED ANALYSIS
by: Nirbhay Jain, MD, et al.
Published: (2022-04-01)

D14. Evaluation of the Relative Safety of Oncoplastic Reduction Compared to Traditional Reduction
by: Elijah Bingham, BS, et al.
Published: (2023-04-01)

The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease
by: Alexis Thomas, et al.
Published: (2010-11-01)

D64. Investigating Same-Day Discharge For Postmastectomy Immediate Breast Reconstruction: A National Surgical Quality Improvement Program Study
by: Elijah G. Bingham, BS, et al.
Published: (2023-04-01)

Effect of Bupivacaine Liposome Injectable Suspension on Sensory Blockade and Analgesia for Dupuytren Contracture Release
by: Catherine F. Vandepitte, MD, PhD, et al.
Published: (2019-10-01)

Dupuytren's Contracture: The Readability of Online Information
by: Shayan Hosseinzadeh MD, et al.
Published: (2021-10-01)

110. A Comparison of Institutional and National Rates of Infection following Dupuytren’s Fasciectomy to Other Common Hand Procedure
by: Toni F. Engmann, Cand. Med, et al.
Published: (2023-05-01)

Efficacy of Collagenase Clostridium Histolyticum for Dupuytren Disease: A Systematic Review
by: Rafael Sanjuan-Cerveró, et al.
Published: (2017-11-01)

Late complications of clinical clostridium histolyticum collagenase use in Dupuytren's disease.
by: Warren M Rozen, et al.
Published: (2012-01-01)

Ultrasound-Guided Collagenase Injection Therapy of Recurrent Plantar Fibromatosis: A Case Report
by: Antje L. Greenfield MD, PhD, et al.
Published: (2023-10-01)

Cost per Episode of Care With Collagenase Clostridium histolyticum Versus Fasciectomy for Dupuytren Contracture: A Real-World Claims Database Analysis
by: Stephen B. Camper, MS, PhD, et al.
Published: (2019-04-01)

Risk Factors for Long-Term Contracture Recurrence after Collagenase Injection for Dupuytren Disease: A Prospective Cohort Study
by: David Eckerdal, et al.
Published: (2023-02-01)

The CeCORD-J study on collagenase injection versus aponeurectomy for Dupuytren's contracture compared by hand function and cost effectiveness
by: Michiro Yamamoto, et al.
Published: (2022-05-01)

Evaluating the Impact of ACGME Resident Duty Hour Restrictions on Patient Outcomes for Bilateral Breast Reductions
by: Purushottam Nagarkar, MD
Published: (2023-09-01)

Using collagenase to treat Dupuytren’s disease: a hypothetical cost benefit analysis
by: Ryan Livingston, et al.
Published: (2019-03-01)

Retraction: Late complications of clinical Clostridium histolyticum collagenase use in Dupuytren's disease.
Published: (2012-01-01)

Collagenase clostridium histolyticum for the treatment of Dupuytren’s contracture: systematic review and economic evaluation
by: Miriam Brazzelli, et al.
Published: (2015-10-01)

A dedicated anticoagulation clinic does not improve postoperative management of warfarin after total joint arthroplasty
by: Joshua S. Bingham, MD, et al.
Published: (2018-09-01)

Does prophylactic local tobramycin injection lower open fracture infection rates?
by: Arun Aneja, MD, PhD, et al.
Published: (2022-12-01)